EcoDrugPlus

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSFCAG00000006913
Gene Symbol: NTRK1
5 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSFCAG00000009081
Gene Symbol: NTRK2
5 Cross references
288 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSFCAG00000014965
Gene Symbol: NTRK3
5 Cross references
271 Possible Orthologues:

Nicastrin

Ensembl ID : ENSFCAG00000003928
Gene Symbol: NCSTN
5 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSFCAG00000015639
Gene Symbol: NAMPT
5 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSFCAG00000015715
Gene Symbol: NISCH
5 Cross references
207 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSFCAG00000009214
Gene Symbol: NOS2
5 Cross references
166 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSFCAG00000023517
Gene Symbol: NOTCH1
5 Cross references
269 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSFCAG00000000914
Gene Symbol: NOTCH3
5 Cross references
201 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSFCAG00000007557
Gene Symbol: NFKB1
5 Cross references
205 Possible Orthologues:

Nuclear Factor Kappa B Subunit 2

Ensembl ID : ENSFCAG00000001242
Gene Symbol: NFKB2
5 Cross references
124 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 2

Ensembl ID : ENSFCAG00000009177
Gene Symbol: NR1H2
5 Cross references
304 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).